Prosecution Insights
Last updated: April 19, 2026

Calidi Biotherapeutics (Nevada) Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18295171 ENHANCED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY KELLY, ROBERT M 1638 Non-Final OA Apr 03, 2023
17952565 CELL-BASED VEHICLES FOR POTENTIATION OF VIRAL THERAPY MARVICH, MARIA 1634 Non-Final OA Sep 26, 2022
17689643 COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER MOLOYE, TITILAYO 1632 Final Rejection Mar 08, 2022

Managing Calidi Biotherapeutics (Nevada) Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month